BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2022 Earnings Ca

Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Related Keywords

United States , Qatar , America , Robyn Karnauskas , Eddie Hickman , Samir Devani , Graig Suvannavejh , Ram Selvaraju , Vince Oneill , Matt Wiley , Sumant Kulkarni , Corinne Jenkins , Vincent Oneill , Richard Steinhart , Rob Risinger , Greg Harrison , Yatin Suneja , Frank Yocca , Colin Bristow , Vimal Mehta , Goldman Sachs , Bioxcel Therapeutics Inc , Qatar Investment Authority , Cancer Institute , Georgetown Lombardi Cancer Center , Nasdaq , Dana Farber Cancer Institute , Bioxcel Therapeutics , Call Transcript March , Bioxcel Therapeutics Fourth Quarter , Full Year , Results Conference , Annual Report , Chief Executive Officer , Chief Financial Officer , Chief Commercial Officer , Vinceo Neill , Chief Rd Officer , Onkosxcel Therapeutics , Chief Medical Officer , Chief Scientific , Commercial Day ,